BGI Genomics

Summary

In 1999 was created BGI Genomics, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in China. The leading representative office of defined Corporate Investor is situated in the Shenzhen.

For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has no specific favorite in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Genedock, F&S Pharmatech, Congenica Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Chemical.

The fund was created by Huanming Yang.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the BGI Genomics, startups are often financed by Cambridge Innovation Capital, Amadeus Capital Partners, Puhua Capital. The meaningful sponsors for the fund in investment in the same round are Green Pine Capital Partners, Volcanics Venture, UEC Group. In the next rounds fund is usually obtained by Volcanics Venture, UEC Group, Parkwalk Advisors.

The top activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. Speaking about the real fund results, this Corporate Investor is 23 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year.